Zhou et al 2020a - Revision history

Rimni at 11:36, 12 February 2021

2021-02-12T11:36:01Z

Rimni: /* 2. Materials and methods */

2021-02-12T11:35:12Z

‎2. Materials and methods

Rimni at 11:32, 12 February 2021

2021-02-12T11:32:58Z

Rimni: /* 2. Materials and methods */

2021-02-12T11:28:04Z

‎2. Materials and methods

Rimni at 11:26, 12 February 2021

2021-02-12T11:26:10Z

Show changes

Dloinng at 04:50, 3 May 2020

2020-05-03T04:50:45Z

Rimni at 13:25, 25 March 2020

2020-03-25T13:25:58Z

Rimni at 13:23, 25 March 2020

2020-03-25T13:23:11Z

Rimni at 13:19, 25 March 2020

2020-03-25T13:19:16Z

Rimni at 13:19, 25 March 2020

2020-03-25T13:19:02Z

@@ Line 134: / Line 134: @@
 |  -
 |  <math>20</math>min after injection
-|-style="text-align:center"
+|-
-| colspan='3' style="text-aling:left;"| TR, repetition time; TE, echo time; FOV, field of view; RT, respiratory-triggered
+| colspan='3' style="text-align:left;"| TR, repetition time; TE, echo time; FOV, field of view; RT, respiratory-triggered
 |}

@@ Line 104: / Line 104: @@
 | style="height:20px"|
 |-style="text-align:center"
-|  rowspan='2' |Injection of Gd-EOB-DTPA
+|  rowspan='2' style="text-align:left;" |Injection of Gd-EOB-DTPA
 | Primovist/ flow rate
 | <math>0.1</math> mL/kg   <math>1</math> mL/s
@@ Line 131: / Line 131: @@
 | style="height:20px"|-->
 |-style="text-align:center"
-|  Hepatobiliary phase images
+|  style="text-align:left;"| Hepatobiliary phase images
 |  -
 |  <math>20</math>min after injection

@@ Line 58: / Line 58: @@
 |-style="text-align:center"
 | style="height:20px"|
-|-
+|- style="text-align:center"
-|  rowspan='4' style="width:400px;padding-right:15px;"|Coronal breath-hold T2W single shot turbo spin echo
+|  rowspan='4' style="width:400px;padding-right:15px;text-align:left;"|Coronal breath-hold T2W single shot turbo spin echo
 | TR/TE
 | <math>1100/80</math>
-|-
+|-style="text-align:center"
 | slice thickness /gap
 | <math>6/1</math> mm
-|-
+|-style="text-align:center"
 | FOV
 |<math> 350\times 346</math> cm
-|-
+|-style="text-align:center"
 |  matrix size
 |  <math>292\times 253</math>
-|-
+|-style="text-align:center"
 | style="height:20px"|
-|-
+|-style="text-align:center"
-|  rowspan='4' style="width:400px;text-align:left;padding-right:15px;"|Axial breath-hold dual-echo(in-phase and opposed-phase) T1W fast field-echo
+|  rowspan='4' style="width:400px;text-align:left;padding-right:15px;text-align:left;"|Axial breath-hold dual-echo(in-phase and opposed-phase) T1W fast field-echo
 | TR/TE1/TE2
 | <math>106/1.15/2.3</math>
-|-
+|-style="text-align:center"
 | stile="width:100px;text-align:left;"| slice thickness /gap
 | stile="width:100px;text-align:left;"| <math>7/1</math> mm
-|-
+|-style="text-align:center"
 | FOV
 | <math>400\times 322</math> cm
-|-
+|-style="text-align:center"
 |  matrix size
 |  <math>244\times 181</math>
-|-
+|-style="text-align:center"
 | style="height:20px"|
-|-
+|-style="text-align:center"
-|  rowspan='4' style="width:400px;text-align:left;padding-right:15px;"|Fat-suppressed dynamic 3D volumetric interpolated breath-hold T1W sequence (before /after injection)
+|  rowspan='4' style="width:400px;text-align:left;padding-right:15px;text-align:left;"|Fat-suppressed dynamic 3D volumetric interpolated breath-hold T1W sequence (before /after injection)
 | TR/TE1/TE2
 | <math>3.6/1.32/2.3</math>
-|-
+|-style="text-align:center"
 | slice thickness /gap
 | <math>5/-2.5</math> mm
-|-
+|-style="text-align:center"
 | FOV
 | <math>320\times 427</math> cm
-|-
+|-style="text-align:center"
 |  matrix size
 |  <math>200\times 250</math>
-|-
+|-style="text-align:center"
 | style="height:20px"|
-|-
+|-style="text-align:center"
 |  rowspan='2' |Injection of Gd-EOB-DTPA
 | Primovist/ flow rate
 | <math>0.1</math> mL/kg   <math>1</math> mL/s
-|-
+|-style="text-align:center"
 |  saline/ flow rate
 |  <math>20</math>ml   <math>2</math>ml/s
-|-
+|-style="text-align:center"
 | style="height:20px"|
-|-
+|-style="text-align:center"
-|  rowspan='5' style="width:400px;text-align:left;padding-right:15px;"|The dynamic enhanced sequence
+|  rowspan='5' style="width:400px;text-align:left;padding-right:15px;text-align:left;"|The dynamic enhanced sequence
 | pre-enhanced phase
 | -
-|-
+|-style="text-align:center"
 | arterial phase
 | <math>20</math>s after injection
-|-
+|-style="text-align:center"
 | portal  venous phase
 | <math>55</math> s after injection
-|-
+|-style="text-align:center"
 | equilibrium phase
 | <math>90</math>s after injection
-|-
+|-style="text-align:center"
 |  delayed phase
 |  <math>180</math>s after injection
 <!--|-
 | style="height:20px"|-->
-|-
+|-style="text-align:center"
 |  Hepatobiliary phase images
 |  -
 |  <math>20</math>min after injection
-|-
+|-style="text-align:center"
 | colspan='3' style="text-aling:left;"| TR, repetition time; TE, echo time; FOV, field of view; RT, respiratory-triggered
 |}

@@ Line 44: / Line 44: @@
 ! Sequences !! Index !! Value
 |- style="text-align:center"
-|  rowspan='4' style="padding-right:15px;"|Axial fat-suppressed RT T2W single shot turbo spin echo
+|  rowspan='4' style="padding-right:15px;text-align:left;"|Axial fat-suppressed RT T2W single shot turbo spin echo
 |  TR/ TE
 |  <math>535/75</math>
@@ Line 128: / Line 128: @@
 |  delayed phase
 |  <math>180</math>s after injection
-|-
+<!--|-
-| style="height:20px"|
+| style="height:20px"|-->
 |-
 |  Hepatobiliary phase images

← Older revision		Revision as of 04:50, 3 May 2020
Line 9:		Line 9:

	<sup>2</sup>Department of Radiology, Harbin Medical University Cancer Hospital, Harbin, China.		<sup>2</sup>Department of Radiology, Harbin Medical University Cancer Hospital, Harbin, China.
−
−	~~<sup>3</sup> College of Mechanical and Electrical Engineering, Harbin Engineering University, Harbin, China~~

	<sup>†</sup>Xueyan ZHOU and Xinxin WANG contributed equally to this work.		<sup>†</sup>Xueyan ZHOU and Xinxin WANG contributed equally to this work.

@@ Line 50: / Line 50: @@
 |  rowspan='4' style="border-top: 1pt solid black;padding-right:15px;border-bottom: 0pt solid black;"|Axial fat-suppressed RT T2W single shot turbo spin echo
 |  style="border-top: 1pt solid black;"|TR/ TE
-|  style="border-top: 1pt solid black;"|535/75
+|  style="border-top: 1pt solid black;"|<math>535/75</math>
 |-
 | slice thickness /gap
-| 7/1 mm
+| <math>7/1</math> mm
 |-
 | FOV
@@ Line 65: / Line 65: @@
 |  rowspan='4' style="width:400px;padding-right:15px;border-bottom: 0pt solid black;"|Coronal breath-hold T2W single shot turbo spin echo
 | TR/TE
-| 1100/80
+| <math>1100/80</math>
 |-
 | slice thickness /gap
-| 6/1 mm
+| <math>6/1</math> mm
 |-
 | FOV
@@ Line 80: / Line 80: @@
 |  rowspan='4' style="width:400px;text-align:left;padding-right:15px;border-bottom: 0pt solid black;"|Axial breath-hold dual-echo(in-phase and opposed-phase) T1W fast field-echo
 | TR/TE1/TE2
-| 106/1.15/2.3
+| <math>106/1.15/2.3</math>
 |-
 | stile="width:100px;text-align:left;"| slice thickness /gap
-| stile="width:100px;text-align:left;"| 7/1 mm
+| stile="width:100px;text-align:left;"| <math>7/1</math> mm
 |-
 | FOV
@@ Line 95: / Line 95: @@
 |  rowspan='4' style="width:400px;text-align:left;padding-right:15px;border-bottom: 0pt solid black;"|Fat-suppressed dynamic 3D volumetric interpolated breath-hold T1W sequence (before /after injection)
 | TR/TE1/TE2
-| 3.6/1.32/2.3
+| <math>3.6/1.32/2.3</math>
 |-
 | slice thickness /gap
-| 5/-2.5 mm
+| <math>5/-2.5</math> mm
 |-
 | FOV
@@ Line 110: / Line 110: @@
 |  rowspan='2' style="border-bottom: 0pt solid black;"|Injection of Gd-EOB-DTPA
 | Primovist/ flow rate
-| 0.1 mL/kg   1 mL/s
+| <math>0.1</math> mL/kg   <math>1</math> mL/s
 |-
 | style="border-bottom: 0pt solid black;"| saline/ flow rate
-| style="border-bottom: 0pt solid black;"| 20ml   2ml/s
+| style="border-bottom: 0pt solid black;"| <math>20</math>ml   <math>2</math>ml/s
 |-
 | style="height:20px"|
@@ Line 122: / Line 122: @@
 |-
 | arterial phase
-| 20s after injection
+| <math>20</math>s after injection
 |-
 | portal  venous phase
-| 55 s after injection
+| <math>55</math> s after injection
 |-
 | equilibrium phase
-| 90s after injection
+| <math>90</math>s after injection
 |-
 | style="border-bottom: 0pt solid black;"| delayed phase
-| style="border-bottom: 0pt solid black;"| 180s after injection
+| style="border-bottom: 0pt solid black;"| <math>180</math>s after injection
 |-
 | style="height:20px"|
@@ Line 137: / Line 137: @@
 |  style="border-bottom: 2pt solid black;"|Hepatobiliary phase images
 |  style="border-bottom: 2pt solid black;"|-
-|  style="border-bottom: 2pt solid black;"|20min after injection
+|  style="border-bottom: 2pt solid black;"|<math>20</math>min after injection
 |-
 | colspan='3' style="text-aling:left;"| TR, repetition time; TE, echo time; FOV, field of view; RT, respiratory-triggered

@@ Line 56: / Line 56: @@
 |-
 | FOV
-| 350<math>\times</math>392 cm
+| <math>350\times 392</math> cm
 |-
 | style="border-bottom: 0pt solid black;"| matrix size
-| style="border-bottom: 0pt solid black;"| 232<math>\times</math>199
+| style="border-bottom: 0pt solid black;"| <math>232\times 199</math>
 |-
 | style="height:20px"|
@@ Line 71: / Line 71: @@
 |-
 | FOV
-| 350<math>\times</math>346 cm
+|<math> 350\times 346</math> cm
 |-
 | style="border-bottom: 0pt solid black;"| matrix size
-| style="border-bottom: 0pt solid black;"| 292<math>\times</math>253
+| style="border-bottom: 0pt solid black;"| <math>292\times 253</math>
 |-
 | style="height:20px"|
@@ Line 86: / Line 86: @@
 |-
 | FOV
-| 400<math>\times</math>322 cm
+| <math>400\times 322</math> cm
 |-
 | style="border-bottom: 0pt solid black;"| matrix size
-| style="border-bottom: 0pt solid black;"| 244<math>\times</math>181
+| style="border-bottom: 0pt solid black;"| <math>244\times 181</math>
 |-
 | style="height:20px"|
@@ Line 101: / Line 101: @@
 |-
 | FOV
-| 320<math>\times</math>427 cm
+| <math>320\times 427</math> cm
 |-
 | style="border-bottom: 0pt solid black;"| matrix size
-| style="border-bottom: 0pt solid black;"| 200<math>\times</math>250
+| style="border-bottom: 0pt solid black;"| <math>200\times 250</math>
 |-
 | style="height:20px"|

@@ Line 261: / Line 261: @@
 ==References==
-<div class="left" style="font-size: 75%;">
+<div class="left" style="font-size: 85%;">
 [1] Imai K., Yamashita Y.I., Yusa T., et al. Microvascular invasion in small-sized hepatocellular carcinoma: significance for outcomes following hepatectomy and radiofrequency ablation. Anticancer Res.,  38(2):1053-1060, 2018.